Advertisement Hemispherx expands bird flu studies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Hemispherx expands bird flu studies

Hemispherx Biopharma has announced further studies in collaboration with US government-sponsored laboratories to determine the antiviral activity of Alferon N against avian influenza.

Previous experimental research has shown that low doses of Alferon N, the only natural alpha IFN cocktail available in the US, added to the water and food supply of the bird population reduced death rate as well as produced healthier weight compared to birds that received placebo.

The Canadian Broadcasting System noted that a mutant form of avian, or bird, flu virus could kill as many as seven million people worldwide and infect nearly one-third of the world’s population, according to the World Health Organization’s projections.

The H5N1 avian flu virus has killed more than 41 of the 54 infected people in Thailand and Vietnam this year and forced Asian governments to kill tens of millions of poultry, in an effort to prevent the spread of the disease to other birds and man.